InsidersTradesSigma
Follow the 진바이오텍 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Food & Beverage sector, 진바이오텍 has published 14 insider filings. Market capitalisation: €41.6bn. The latest transaction was filed on 14 July 2026 (Purchase). Among the most active insiders: 김성호. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
n/a
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,130 of 29,063 companies
57.5
score / 100
Value79
Quality37
FCF yld9.6%
Earn yld9.4%
EV/EBITDA8.7x
ROE·
Gross mgn16%
Net mgn4.2%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 July 2026
Declarations14 total
Other
14 of 14 declarations
Acerca de 진바이오텍
진바이오텍 es una empresa del sector agroalimentario que cotiza en el mercado XKRX. Se especializa en el desarrollo de productos biológicos y soluciones innovadoras para la agricultura.